Latest / Psychopharmacology Today / Ep. 3: Science vs. Pseudoscience of Medical Cannabis
Transcript
- 0:05My name is Jeff DeBerry.
- 0:06I am a senior online admissions counselor for Alliant International University.
- 0:10I'm very happy to be here to present our speaker, Dr.
- 0:12Randall Tackett, speaking on Science vs.
- 0:15Pseudoscience of Medical Cannabis: What Clinicians Need to Know.
- 0:18Randall Tackett received his PhD in pharmacology and toxicology from the University of Georgia.
- 0:24After completion of a postdoctoral fellowship at the Medical University of South Carolina, he returned to the University of Georgia College of Pharmacy as an assistant professor.
- 0:26Dr.
- 0:33He is currently a professor and associate department head in the Department of Clinical and Administrative Pharmacy and the director of the Clinical Trial Certificate Program in
- 0:41Regulatory Affairs.
- 0:42He also holds adjunct faculty appointments at Alliant International University and Fairleigh Dickinson University.
- 0:48He has given numerous lectures about dealing with adverse drug interactions, cardiovascular disease, substance abuse, psychopharmacology, and forensic pharmacy.
- 0:57He is recognized as an expert in pharmacology and toxicology and substance abuse.
- 1:02So I will give you the floor, Dr.
- 1:04Tackett.
- 1:04Well, thank you very much, Jeff.
- 1:06I will
- 1:07to you that I used to say that marijuana would never be legalized in my lifetime.
- 1:11And that's one of those things that I tell my students: never to say never.
- 1:15Just like when I left the University of Georgia with my doctorate, I said I was never gonna come back and I've been here, I think it's 44 years now.
- 1:22One of the things that's prompted giving these talks is medical associations have been contacting me specifically because suddenly their states are legalizing medical marijuana.
- 1:32Even though marijuana has been around for a long time, the question is, what do we need to know?
- 1:36And there's a lot of misinformation out there.
- 1:38I put this statement up ever since I've been doing this talk, even before the medical associations.
- 1:44And I think it sort of gives a good background of what we're dealing with.
- 1:49Carlini basically said in 2004, "Very few drugs, if any, have such a tangled history as a medicine.
- 1:50E.A.
- 1:56In fact, prejudice, superstition, emotionalism, and even ideology have managed to lead cannabis to ups and downs concerning both its therapeutic properties and its toxicological
- 2:06and dependence-inducing effects." So that is, in fact, what we're running into.
- 2:11As we are looking at the landscape of legalizing medical marijuana,
- 2:15some people want it legalized for the medicinal aspects of it.
- 2:19And as I will talk about tonight, there are therapeutic aspects there.
- 2:24When we talk about marijuana, I'll be using the term cannabis a lot because we have several different components, not just the Delta 9 THC, but we also have people that want
- 2:34the medical marijuana legalized with the idea that if medical marijuana is legalized, it'll make it easier for recreational.
- 2:41Some people think it's much better as a medicine because it's natural.
- 2:46People have compared it's safer than alcohol for recreational purposes.
- 2:50So there's all these different agendas that are going around.
- 2:53What I'm hoping to do tonight is to give you some foundation because even in states where medical marijuana has been legalized, one of the things we're learning is clinicians don't
- 3:03really know
- 3:04what they need to tell their patients.
- 3:05And a lot of people have gotten information regarding marijuana off the internet.
- 3:10And some of that information has some truth to it.
- 3:13Some of that information may have no truth to it whatsoever.
- 3:16And some of it may be sort of in a gray area, a little bit of truth and a little bit of maybe not so much truth.
- 3:22So when we look at marijuana, from a standpoint of medical marijuana,
- 3:26when you're dealing with the lay public in particular, there is a distinction between recreational and medical marijuana.
- 3:33I even have students here at University of Georgia who basically have been arrested for marijuana because they're going, well, it's legalized.
- 3:40And I'm going, yes, it's legalized for medical purposes.
- 3:44It doesn't mean it's legalized for recreational purposes.
- 3:47So we see that there is a distinction between recreational versus medical.
- 3:51With any drug, one of the big considerations that we have to take into a place, if you're gonna prescribe marijuana, if one of your patients are taking marijuana for medical
- 4:01purposes, there is still the old aspect that we do for any drug: What is the benefit versus the harm?
- 4:08And hopefully at the end of this, I will have given you some examples of where benefit may occur, where the harm may occur.
- 4:15And you're really making a risk assessment if you are one of these people that are either going to prescribe marijuana or one of the people that may be using marijuana.
- 4:24And then the other thing that just sort of throws a lot of confusion in the mix is states have different laws versus federal.
- 4:32We had a gentleman not too long ago that got arrested for marijuana possession.
- 4:37I was contacted and his argument was, but I have a prescription.
- 4:41And there was two things wrong with that.
- 4:42One is that prescription was good in the state that he, got the prescription for.
- 4:47And secondly is, to my knowledge, none of our, street vendors, the guys that are selling marijuana in the corners or in the parking lots,
- 4:54require a prescription, but he thought as long as he had a prescription, everything was fine.
- 4:58That is not always the case.
- 5:00But it adds to a lot of confusion; adds to a lot of issues where patients may be given medical marijuana in one state, but there's an issue with getting it in the other state.
- 5:10The other thing that has come into play when we talk about cannabis, marijuana, is we have the CBD.
- 5:16CBD is in most states legal.
- 5:19We see CBD present in a number of different venues such as vape shops.
- 5:25We even see, for example, one of my students was using CBD and I asked them where they got it from and they were getting it from the tractor supply store.
- 5:34I've even seen CBD in the pet food stores.
- 5:38When I go get, you know, pet food for my dog, there's a whole line of hemp
- 5:42CBD products.
- 5:43The issue is that the FDA probably does not even know how many particular CBD products are.
- 5:50We also see that CBD and the term "hemp" are used a lot for marketing.
- 5:55So a lot of products are yelling or basically advertising that they are hemp-based or they're CBD.
- 6:02But we do see there are probably well over a thousand different products
- 6:06that people get through the internet, get through dispensaries, pharmacies, national retail stores, and some of these boutique shops.
- 6:14So there's just a lot of places.
- 6:15There's been very extensive media coverage about CBD.
- 6:19And there is an estimate that international business, it's probably in excess of $60 billion.
- 6:25So it's a very lucrative business.
- 6:27It's being used to add to the advertising of a lot of things when people are saying they put a little bit of CBD in it.
- 6:35I've seen vitamins that now say we have CBD or hemp.
- 6:38When we talk about CBD, when we talk about cannabis, we talk about THC, health care really was unprepared for this.
- 6:45And we see that now, for example, in some states, they have legalized medical marijuana, and I've gone to those states to give talks because they need to know what do we need to
- 6:54know about this.
- 6:55And my bottom line is, well, I can tell you a lot about it, but the reality of it is, although your state
- 7:01has legalized marijuana, it does not have any recognized dispensaries.
- 7:05So even if the state has legalized medical marijuana, you have no place to get it.
- 7:10One of the things was that THC was a schedule one, and that produced a lot of roadblocks for us doing scientific studies on those.
- 7:20The other issue that comes into play
- 7:22is street marijuana the same as what we would see from, you know, that we would get from a dispensary or whatever.
- 7:28And then CBD, which gets sort of mixed in there.
- 7:31Basically, we've had very limited studies that actually have looked at CBD alone.
- 7:37So there is a limitation of the studies.
- 7:41Now, we've had recently a drug that was approved in the last several years, Epidiolex,
- 7:45which is the first botanically extracted CBD product or cannabis product.
- 7:50But the issue was a lot of our safety studies and so forth are based upon that.
- 7:54Regardless of this limitation of information, we see CBD and cannabis and hemp products touted as pretty much a cure-all or a panacea for just about everything.
- 8:06If you look at the number of diseases
- 8:09that supposedly are treated by this...
- 8:12people talk about that it's effective for anxiety.
- 8:15It's good for cannabis use disorder, Crohn's disease, diabetes, epilepsy, Huntington's disease, Parkinsonism, opioid use disorder, schizophrenia, psychosis, cancer, sleep
- 8:29disorders, pain.
- 8:30There are
- 8:31studies that suggest that cannabis THC may be therapeutic.
- 8:38But on the other hand, we have to look at what we're getting in the marketplace and how pure it is and what the dose is.
- 8:46So when we look at cannabinoids, first of all, our body makes, we have some endogenous cannabinoids.
- 8:52We refer to those as endocannabinoids.
- 8:54They basically are derived from arachidonic acid.
- 8:57Arachidonic acid is basically the precursor for prostaglandins and thromboxins and several other endogenous components.
- 9:05So we do know there's an endocannabinoid system and that it serves as a modulator for other transmitter systems.
- 9:11When we look at phytocannabinoids, these are plant-derived cannabinoids.
- 9:16There are hundreds of naturally occurring compounds in cannabis sativa.
- 9:21This includes THC, it includes cannabinol, also includes cannabidiol.
- 9:28Those are the ones that seem to be the central component, but these others sort of get lumped in.
- 9:34And then we have synthetic cannabinoids.
- 9:35These are basically laboratory-produced congeners of THC and CBD.
- 9:41Now, some of these synthetic cannabinoids can be pretty nasty.
- 9:44Since we've had legalization of medical marijuana, a lot of people think that
- 9:49all THC is the same.
- 9:51So phyto cannabinoids THC, Delta 9 that comes from the plant is similar to what you see with synthetic cannabinoids.
- 9:59And some of these synthetic cannabinoids are pretty toxic and have some pretty negative things.
- 10:03But people think about synthetic as, we've just made it in the laboratory.
- 10:07So we have to be careful about that.
- 10:08If you look at the different cannabinoids, what you're going to see is, everybody is familiar with THC and specifically the Delta 9 THC.
- 10:16The Delta 9 is the product that's psychoactive.
- 10:20It produces the euphoria.
- 10:21Increased reaction time means it really takes you longer to react.
- 10:24We've seen some loss of memory and cognition.
- 10:27We've seen several negative aspects of THC.
- 10:32What we have to be aware of is Delta 9 is the one that most people are aware of.
- 10:37We're also seeing that Delta 8 and Delta 10 THC are showing up.
- 10:42And the reason they're showing up is because of the farm bill, which allowed hemp products to be marketed.
- 10:48So one of the biggest things that I'm running into, especially with professionals, professional students,
- 10:54they're using gummies and they're buying gummies from various different places off the internet, tractor supply, as I've said.
- 11:01And those gummies are legally sold.
- 11:04But one of the things we're seeing is, although they have CBD in them, they're also being spiked with Delta 8 and Delta 10 THC, which is creating a problem.
- 11:14Delta 8 in particular can have some properties similar to THC.
- 11:19It's not quite as potent.
- 11:20But when you see the amount of Delta 8 that gets put into these gummies, it becomes significant.
- 11:26Cannabinol basically has been touted as being analgesic.
- 11:31It's been used to improve sleep.
- 11:33There is laboratory data which suggests that it promotes the growth of bone cells and may actually promote healing,
- 11:40and maybe even be something that could help in osteoporosis.
- 11:44It is anti-inflammatory, anti-convulsant.
- 11:47It's an appetite stimulant.
- 11:49The big one we see that comes out is CBD.
- 11:51And there is something about CBD that is very positive.
- 11:55CBD has been shown to modify the THC effects.
- 11:59In other words, it will antagonize some of the negative aspects of Delta 9.
- 12:03Often, most states have the laws written that say that you have to have a certain amount of CBD.
- 12:09Usually it's an about a one to one ratio, CBD also
- 12:13will prevent the conversion of THC to the 11-hydroxy-THC, which is an active metabolite.
- 12:19And we don't see formation of CBD from THC.
- 12:24It doesn't occur necessarily from smoking or by metabolism.
- 12:28We do see CBD as a pretty good anti-anxiety drug and can also offset some of the psychological side effects that we actually see with
- 12:38Delta 9 THC.
- 12:39The other compound that I have down here is carboxyl THC.
- 12:44It's inactive, but this is what stays around.
- 12:47One of the things that happens when people use THC, one of the metabolites that happens is the carboxyl and that will flag a drug test.
- 12:54When we see people that are smoking heavily or using THC heavily, this carboxyl metabolite, the inactive metabolite can stay around for several hours or days.
- 13:04In fact, in very heavy chronic users, it's estimated it may stay around about 30 days.
- 13:10So this basically would tell us that someone has used marijuana, but it doesn't tell us when they used it and they're not under the influence of it if this is all that is
- 13:18present.
- 13:18When we look at THC and the cannabinoids, as pharmacologists, what I do is we always want to one, are there receptors for it?
- 13:27And two is, where are those receptors?
- 13:30So what we know, and this has been known for a good while, is that we do know that there's CB1 receptors that are located in various aspects of the brain.
- 13:39And for example, in the medulla,
- 13:40in the cerebellum, the basal ganglia, the cerebral cortex, the hypothalamus, the hippocampus, and the spinal cord.
- 13:47There are some things that are involved in those particular areas that we know anatomically those areas control.
- 13:53And so if those receptors are activated or stimulated by THC or cannabinoids, it gives us an example of how the drugs may work.
- 14:02So for example, we do know that people under the influence of marijuana may have difficulty moving.
- 14:08They could be staggering.
- 14:09They can have difficulty walking, things like that.
- 14:11And we do know that by activating receptors in the basal ganglia and the cerebellum, that that would account for the movement disorders that we have.
- 14:21We know that marijuana can affect cognition.
- 14:24We have CB receptors in the cortex.
- 14:27We know that one of the big things that always comes up is marijuana should be legalized because of its anti-emetic effects, that it is a very good drug for inhibiting nausea.
- 14:37We'll come back to that.
- 14:39The hippocampus is where, as most of you know, learning occurs and that can affect learning and memory.
- 14:47And we do know that some of the peripheral sensation, including pain,
- 14:51occurs in the spinal cord.
- 14:52And that's been one of the things that people have thought about is if we could activate those receptors or interact with those receptors, this may be a good analgesic drug.
- 15:01We see a lot of CB1 receptors in the central nervous system.
- 15:05And these areas account for the pleasure, the movement disorders that people may have, interference with learning, interference from cognition, and may even alter people's
- 15:15perception to pain.
- 15:16We know that marijuana acts in the reward center, the Mesolimbic Reward Center, so that is one of the reasons that we get the euphoria and could also contribute to the potential
- 15:26addiction aspects of marijuana.
- 15:28In the cerebellum and the basal ganglia, some of the negative things we see is lack of coordination, clumsiness.
- 15:35We really see this more common in the recreational users, but when we are using this as a therapeutic agent, what we do find is, for example, those actions in the cerebellum and
- 15:47basal ganglia, as well as maybe even the spinal cord, may come into play with regard to relieving spasticity.
- 15:54And so one of the things that we have seen therapeutically is these cannabinoids are useful in some of these severe spastic
- 16:02Mood can be modulated.
- 16:04Of course, everybody thinks that when you are smoking weed, basically you're in just this euphoria, pleasant mood.
- 16:11But we also see that individuals can have some alternative responses other than just being, you know,
- 16:17sort of chilled out and everything.
- 16:19We do see panic attacks.
- 16:20We do see some psychosis that may occur.
- 16:23Again, we have the prefrontal cortex, the hypothalamus, the munchies are well recognized with people that are using marijuana.
- 16:32And again, the spinal cord, especially the dorsal primary afferent tracts and those tracts going up into the central nervous system may be responsible for the analgesic affections.
- 16:42Basically looking at pharmacology, we have receptors that are targeted and those receptors are in specific areas that give us a good idea of what to expect with someone that is
- 16:53using these drugs.
- 16:54Of course, the dopaminergic pathways and the reward center, that is going to be important for abuse and dependence.
- 17:01One of the misperceptions people have is there's a lot of people that say marijuana is much safer than alcohol and other drugs because people don't get addicted to marijuana.
- 17:11But we actually do know there is marijuana use disorder.
- 17:14We do know that there are issues that occur, and that is explained by the actions in these reward centers.
- 17:21Now, another interesting thing is that there's very few receptors actually in the brainstem.
- 17:27So one of the other things that comes into play is because there's few receptors in the brainstem, there's minimal effects on the autonomic nervous system directly by the drug.
- 17:37And in fact, one of the big things was people can say, for example, with alcohol, they can kill themselves by drinking too much.
- 17:44So for a long time, we said there is no known lethal overdose that's reported with THC.
- 17:50Now, we had people that died when they were using THC because maybe they were in a car wreck or some other thing that was secondary.
- 17:57They drowned or whatever.
- 17:58But there's always an exception to every rule.
- 18:01And not too long ago, we did see someone actually overdose on marijuana.
- 18:05However, I will tell you
- 18:07it was a very, very, very large amount of marijuana.
- 18:10And that was written up, I think, in the New England Journal of Medicine.
- 18:13The other issue that comes into play is, first of all, when we're looking at marijuana, we have to realize that, what we would see in the dispensaries and what we grow may not be
- 18:23the same stuff we see on the street.
- 18:25There is some differences in potency and actually maybe some differences in the constituents of this particular cannabinoids.
- 18:31We also know
- 18:33that we can see certain compounds that are present in the raw marijuana, in the raw botanical.
- 18:41We also know that once it is heated, which is a very common way that people, either smoke it or cook it up in certain recipes, that we can get some other compounds.
- 18:51And then we also may see different compounds once the drug is aged,
- 18:55we can see some slightly different profiles.
- 18:57There are so many different variations of what you may be actually looking at, even in medical marijuana as to the constituents and the concentration.
- 19:06Now, I'm going to take a step back from the marijuana and let's go to, do we have any cannabinoids that are actually available as drugs in the United States?
- 19:18And the answer is yes.
- 19:19One drug that's been around, and it's a synthetic THC, one of the drugs is dronabinol and it's been around since 1985.
- 19:28And an interesting thing about dronabinol,
- 19:31is if marijuana was really as good as everybody makes it out to be as far as a therapeutic agent, dronabinol would be in the top 300 drugs.
- 19:41And I don't think it has ever been in the top 300 drugs.
- 19:44But in addition to dronabinol, we also have nabilone and we also have Epidiolex that is was recently approved, which was the CBD.
- 19:53So dronabinol and nabilone is THC,
- 19:56where Epidiolex is primarily CBD.
- 19:59Canada, we have Nabixamols, and in Europe, we also had a drug called Rimanabant, and that one was actually tried to get approved in the United States, but one of the major issues
- 20:10occurred was in the studies, there were concerns over depression and suicide, so it never got approved here in the US.
- 20:17If you looked at Dronabinol, trade name was Marinol,
- 20:20it was actually approved in 1985, synthetic THC, and it was approved primarily for chemotherapy-induced nausea and vomiting.
- 20:29And that was a big component that people pushed for marijuana, getting it approved, is all these people undergoing chemotherapy, they suffer terrible nausea, and marijuana helps
- 20:39alleviate that.
- 20:40The other thing we saw this used for is, since THC,
- 20:44can stimulate appetite, we found that using this was very good in patients that had AIDS, especially that became anorexic or even elderly patients that may be suffering from a
- 20:55wasting syndrome.
- 20:56They just weren't eating.
- 20:57So the idea was Marinol was approved to stimulate appetite.
- 21:01In other words, generate the munchies in these individuals.
- 21:06Another drug, THC analog, pretty much the same as dronabinol.
- 21:09What we find is it differs a little.
- 21:13One, dronabinol basically takes about 30 to 60 minutes to kick in, but lasts about six hours.
- 21:20Nabilone takes about 60 to 90 minutes, but lasts up to 12 hours.
- 21:24So what we're seeing is...
- 21:25variation in the pharmacokinetics, but the anti-emetic effect was basically about the same.
- 21:32And the other thing was it was approximate or slightly greater to that that we saw with phenothiazines, which tend to produce a lot of sedation.
- 21:42With these two drugs, what we saw was there was a very narrow gap between the dose that you needed to get the effect and the adverse effects.
- 21:51So in a naive user, they would
- 21:53potentially experience the euphoria, which you might say maybe that's not too bad in these patients.
- 21:58But we did see some dysphoria, which we don't want, some cognitive clouding, which could interfere with their quality of life and their ability to do different things.
- 22:07They were drowsy and they were dizzy.
- 22:09And so these adverse effects were more problematic when they first started with it.
- 22:13But as they developed a tolerance, they were able to manage that.
- 22:17Couple of things that occurred with these drugs is even though they're pharmaceuticals and they went through the FDA and were approved and so forth, we did see some variable
- 22:26absorption and some first pass effects.
- 22:28So it really gave us a little bit of unpredictable blood levels.
- 22:31So some variation, but here's where their use really dropped off.
- 22:35As I mentioned just a moment ago, they were more effective generally than some of the drugs we had.
- 22:40But then we had a new drug that came out, which basically worked on serotonin receptors.
- 22:45This was odansetron which you guys probably have heard of as Zofran.
- 22:50And Zofran, when it came on the market, it was much more potent, more predictable than these drugs, very minimal psychotropic effects.
- 22:56And we even had an IV dose, which if somebody was really nauseous, you would want to give them that.
- 23:00So the bottom line was
- 23:02odansetron when it first came out, was very expensive.
- 23:05I remember my daughter getting some odansetron after some surgery when we took her home from the hospital, I think they gave us three tablets and each tablet was like six or
- 23:13eight bucks.
- 23:14But now odansetron is generic and pretty cheap.
- 23:17But we don't consider these drugs really first line agents for nausea anymore.
- 23:23What we find is
- 23:24when individuals don't respond to first line therapies, that sometimes we will use dronabinol, nabilone, and in some cases people will, you know, smoke weed to get the Delta
- 23:349 THC.
- 23:35CBD was the other one and it's in botanical preparation.
- 23:41So it's in the plant.
- 23:42But one of things we see is that CBD's concentration is in the plant may vary.
- 23:47The big thing about CBD was it doesn't have the psychoactive properties.
- 23:51We actually find that THC tends to produce anxiety and paranoia.
- 23:56And if that is already present in a patient, it could
- 23:59actually exacerbate it.
- 24:00And we find that CBD tends to mitigate that.
- 24:03And in fact, we find that it may, on certain things, may actually act synergistically with THC.
- 24:09CBD by itself in the right dose may have anxiolytic properties, even some antipsychotic properties.
- 24:15And it has also been shown to have some anti-convulsant properties and some neuroprotective properties.
- 24:21Where we're seeing CBD use now is these spasticity problems.
- 24:25And that's what it was actually approved for, was some of these severe spastic issues.
- 24:30So if you compare THC and cannabidiol, THC can produce the euphoria, can produce anxiety, psychosis, cognitive impairment, and increase appetite or cause hunger.
- 24:41Cannabidiol doesn't produce the euphoria.
- 24:43is anti-anxiety and psychotic, doesn't appear to produce cognitive impairment at most of the doses that we would use, but it doesn't have an effect on appetite.
- 24:51So if we're trying to stimulate appetite, CBD just doesn't get it.
- 24:55Nebiximol, which is Cetivex, which is available in Canada, and they've had some trials in the US, this was approved for cancer pain and neuropathic pain such as in multiple
- 25:06sclerosis.
- 25:06Now, the reason I wanted to bring this up is because I want you to note something.
- 25:10This is available as an oral spray, but notice the concentration.
- 25:14It is about 50-50 THC CBD.
- 25:18It contains both THC and CBD, and this drug seems to work pretty rapidly.
- 25:24It doesn't produce the sedation and memory impairment that you see with THC.
- 25:29And what we find is that the peak concentrations of THC are much lower.
- 25:35It's estimated over 20-fold lower than someone that would be smoking cannabis.
- 25:41So with a lower level of THC,
- 25:44the belief is there's a lower potential for dependence.
- 25:46A lot of states have in their medical marijuana laws that the compounds that are available should have like 50-50.
- 25:54And then Epidiolex, it's a purified form of CBD.
- 25:57It is plant-derived.
- 25:59They use it for severe forms of epilepsy and movement disorders.
- 26:02And it was actually scheduled as a schedule one.
- 26:05It can't be a schedule one because schedule one says there's no medical use, but it went from a schedule one down to a schedule five; one of the lowest schedules we have.
- 26:14But there is a warning for Epidiolex, even though it is only CBD, there's a label warning that you could fail a drug test; you could test positive for THC.
- 26:23So we tell patients that they potentially could test positive for THC on a cannabis drug screen.
- 26:31Many of the drug screens just say THC or metabolites.
- 26:34I've run into situations where people that have been using CBD, not the Epidiolex, but CBD that you would see in gummies and so forth like that, that have failed a drug test, have
- 26:44lost their jobs or have had to go to court to try to get their jobs back.
- 26:48Primarily, I've seen that in academia, law enforcement, and healthcare.
- 26:53Another interesting thing is these CBD products, which we purchase legally, there was a recent article in the Journal of American Medical Association.
- 27:03They actually got 84 CBD products that they bought from online distributors.
- 27:0884 products, 31 different online distributors.
- 27:1370% of those products
- 27:15had different levels of CBD than specified on the label.
- 27:18Half the products had more CBD than indicated.
- 27:21About 25% of the products had less CBD than indicated.
- 27:25In 18 of the samples, Delta 9 THC was present.
- 27:28There was a concern about Epidiolex with its off-label use, people trying to use that to get high by using high dosages.
- 27:36Probably the cost prohibits that because you're looking at about three grand per month at a prescription level that you would need.
- 27:43However, people that are using CBD, one of the things that could potentially happen is that CBD, if someone used it off-label, wrote a prescription for that, for anxiety or
- 27:55something like that, then that
- 27:57could offer some advantages, although insurance is not going to approve it, and it's going to be awful expensive.
- 28:04What we do see with CBD, now this is assuming that we have a relatively pure form of CBD.
- 28:11Most of that has come from the Epidiolex clinical data.
- 28:14And we see that liver enzymes increase and there is potential for liver injury.
- 28:20So that's something we might wanna monitor.
- 28:22We do know that it goes through the cytochrome P3A4.
- 28:26And as most of you know, 3A4 basically is one of the most common
- 28:32drug enzymes involved in drug metabolism.
- 28:35And it also goes through 2C19.
- 28:37But we do see that there is the warning that if CBD is used with other CNS depressants, that there may be an increased risk of drowsiness or sedation.
- 28:47So that's sort of just a generic warning that is given.
- 28:50When we look at when you do not wanna use cannabis products, ultimately someone has to make a decision does the benefit outweigh the risk?
- 28:58So typically when not to use it is if, as like with every drug that's out there, if there's a hypersensitivity to it.
- 29:04It's not recommended for use under the age of 25, even though some of the patients
- 29:10are young children that Epidiolex is being used.
- 29:12If there is a history, either personally or family history of psychosis or schizophrenia, cannabis use disorder, or any other active substance use disorder, it's not recommended.
- 29:22Pregnant or breastfeeding, we know these drugs will get across the milk and get into the fetus also.
- 29:28And then if there's any significant cardiovascular or pulmonary disease, that's sort of the general contraindications
- 29:34for this use of cannabis.
- 29:35One state that has given us some interesting information is Colorado, because Colorado was one of the first states that sort of legalized marijuana.
- 29:43In March of 2015, there was a lab that went to the certified growers and sellers.
- 29:48These are the ones that have been approved to grow the marijuana to sell legally and the ones that are selling it.
- 29:55They gathered a bunch of bud;
- 29:57literally 600 samples.
- 29:59The average THC level was almost 19%.
- 30:02some of those retail pot samples contained 30% THC or more.
- 30:09When you're getting these products, one of the big things that you got to be aware of is you're not sure how much you're getting.
- 30:15It's sort of like:
- 30:16Would you take any other medication where someone says, here's your asthma inhaler and you should be getting, you know, 15 milligrams of this with each puff, but it may be 30
- 30:25milligrams or maybe a little less.
- 30:26So that is a concern.
- 30:28With medicine, we're wanting to dose and many things are dose-related and we want to have enough to get an effect, but we also don't want to have too much.
- 30:35The other interesting thing was
- 30:37in these samples, they found little or no cannabidiol, CBD.
- 30:42And remember, one of the things is CBD offsets some of the negative aspects of the THC.
- 30:48The average CBD amount was like 0.1%.
- 30:51So you had, in some samples, 30% THC, but only 0.1% CBD.
- 30:58So that was a big concern.
- 31:00Again, not knowing what we're getting
- 31:02but also not knowing the amount that we're getting.
- 31:05The other thing that comes into play is when we're looking at recreational versus medical use, there's a different method of use.
- 31:10For example, medical, we're going to have gummies.
- 31:14That's a new popular thing.
- 31:15People are vaping.
- 31:16One of the issues is that altering these vape pens and vape pods can create some very serious things.
- 31:22There's impurities that can be in there.
- 31:24That's going to be a big concern.
- 31:25And the other thing is, if any of you grow, for example, jalapeno peppers, you know if you water the plants really well that they're gonna dilute, they're not gonna be as hot.
- 31:34Whereas if you don't water them or you're in a drought, you tend to get those much hotter peppers.
- 31:39Same thing happens with THC in plants.
- 31:42And so one of the things people have said, well, maybe we can have a centralized source of cannabis.
- 31:47I can tell you right now that many people that want to use cannabis do not want the government basically providing their cannabis for them.
- 31:55The other thing is that addiction can occur.
- 31:57So we've got to be monitoring individuals for the potential for addiction and doing the appropriate things for preventing addiction.
- 32:04A lot of contaminants that can show up on the street; we find
- 32:09various fungi and bacteria that may be on products.
- 32:11People use organophosphate pesticides, which you're gonna inhale.
- 32:15And on the street, we find that sometimes the products are actually contaminated with glass beads and sand.
- 32:21That increases the weight and that can be inhaled and cause some serious damage.
- 32:26We do know THC and other components of marijuana, the other cannabinoids, can actually affect neurotransmitters and how cells grow.
- 32:34The question is, to what extent?
- 32:36We know that it can stay in the body for weeks, especially in maternal tissues.
- 32:41There's some dog studies that suggest that they stay there.
- 32:44We know that it deposits in the fat and sometimes if it's heavy use, it can be slowly released.
- 32:48We know it crosses the placenta.
- 32:50It can go through mother's milk.
- 32:52So there's a lot of exposures that we have to be very, very aware of.
- 32:56The other thing is what we're seeing is concentrations of THC has increased significantly since the 70s, 25-fold.
- 33:04One of the concerns is that in edible forms, the gummies, it may even be even more.
- 33:09From a standpoint of pregnancy, we know it can interfere with folic acid, and we know that animal studies tell us that THC
- 33:15may be involved in development, and these have been done with mouse embryos.
- 33:19Of course, we can't ethically do these in humans.
- 33:21The other thing we saw from the Colorado data, we saw that several patients after legalization were actually hospitalized.
- 33:29They show up in the ER; severe hallucinations, no gag reflex, difficulty breathing, and they were actually getting synthetic THC and they were being touted as being
- 33:40you know, again, legal marijuana, and some of these products actually had, names on them or logos on them such as "botanical sachet," "sexy monkey," and "crazy monkey." Sometimes
- 33:49what we actually see being sold as synthetic THC sometimes are very similar to what we see in bath salts.
- 33:54Does it cause addiction?
- 33:55We say, yes, we have seen marijuana use disorder.
- 33:59Estimated that about 30% of those who use marijuana may actually have a marijuana disorder.
- 34:03And we see that the earlier they use them, they're more likely to develop marijuana disorder.
- 34:09And typically, we're going to see that there is an alteration in the endocannabinoid receptors.
- 34:16We're now getting some research that
- 34:17is giving us more insight into what's occurring.
- 34:20But again, many people thought marijuana was much safer than even alcohol or even cigarettes because they did not recognize the marijuana use disorder.
- 34:2910 years ago, we estimated 4 million people met the criteria for marijuana use disorder.
- 34:35Here's something that emerged and it's a term called scromiting.
- 34:38It's also known as cannabis hyperamesis syndrome.
- 34:42The reason it's called scromiting is because when people vomit due to this, remember a lot of people tout marijuana as an anti-emetic, an anti-vomiting compound, it's so painful
- 34:52that they scream when they vomit.
- 34:54So it's been termed scromiting.
- 34:56This typically occurs in males
- 34:58that are using marijuana multiple times per week for greater than a year.
- 35:02That puts them at the highest risk, although we've seen it in individuals using it a lot less.
- 35:07When they stop the marijuana use, it goes away.
- 35:10It's related to the THC concentration.
- 35:12In the 90s, a typical joint would have about one to three milligrams of THC.
- 35:16Currently, it's estimated a single joint has 18 milligrams.
- 35:21We don't see this with CBD, but we see it with THC.
- 35:24Couple of slides here, which I use a lot.
- 35:27This is a normal brain on your right.
- 35:30And these are some scans.
- 35:33On your left is a 16-year-old that has a two-year history of daily abuse.
- 35:39These are not physical holes in the brain.
- 35:41They are basically areas where functioning has been decreased.
- 35:45So we do see some pretty significant brain changes.
- 35:49And that is consistent with the pharmacology.
- 35:51Here's another, you've got a 18-year-old with a three-year history, four times a week smoking weed.
- 35:57Again, when we're dealing with this, we don't know exactly how much THC they were getting since this was street marijuana.
- 36:02And then you can see several scans here showing various use.
- 36:06And here's one with 12 years and some pretty significant brain changes that have occurred.
- 36:11So one of the big things that the medical associations have come to me with is, are prescribers prepared?
- 36:17There's been studies that actually surveyed medical school deans, residents, and the results were 75% of medical school deans said their graduates were not at all prepared or
- 36:28only slightly prepared to answer questions about medical marijuana.
- 36:3294% of those same people
- 36:34said that their graduates were not prepared or only slightly prepared to prescribe marijuana.
- 36:39So that is a big issue.
- 36:41And all these things have been touted as having health benefits.
- 36:44And the National Academies of Sciences in 2017 came out and said; they looked at the different evidence.
- 36:49And what they said is, there is substantial or conclusive evidence that medical marijuana can be helpful in chronic pain, can be helpful in chemotherapy-induced nausea and
- 36:59vomiting, and spasticity associated with multiple sclerosis.
- 37:03With regard to some other things, you have to look at benefit/risk with the idea that, even with the medical marijuana, you have to recognize there may be impaired cognition,
- 37:13may be an increased chance of motor vehicle crashes because of impairment, addiction, lower birth weight, all of those have to be factored in.
- 37:20But what we find is that
- 37:22insufficient evidence exists for the use of medical cannabinoids for which its use is advocated.
- 37:28If you look at a lot of states, there is over 50 medical conditions that they approve or allow medical marijuana to use, and there's no evidence for it.
- 37:36That's a big issue that we're dealing with right now: there is a lot of compounds which there's not strong evidence for its benefit.
- 37:44Elderly risk of falls are a big concern, especially if they're using other central nervous system drugs or blood pressure meds.
- 37:54We have no control over specifically, as I showed you the data from Colorado, we don't know what they're actually getting in the dispensaries because most of these states have
- 38:04not established the issues associated with these dispensaries.
- 38:09And a lot of patients can't even tell you how much THC or CBD they're on.
- 38:12I had a patient just recently I just said, "How much on a gummy?" And he said, "It's 50 milligrams." And I said, "50 milligrams of what?" And that's all it said on the package
- 38:20insert.
- 38:21So I had no idea was that CBD or whatever.
- 38:23Now, the other thing is we find that what's available even over the counter
- 38:28is that products can be mixtures of THC and CBD.
- 38:32They can be THC-dominant, so more THC than other things.
- 38:36They may be CBD-dominant, which means there's CBD, but they can still have THC.
- 38:40And there may be several other cannabinoids.
- 38:42We just don't know.
- 38:43And the FDA doesn't check for safety before these go out over the counter, but the FDA can step in if there's a problem with that.
- 38:51When you see THC side effects, basically you're going to see nausea, dizziness, increased appetite, euphoria, things we've talked about.
- 38:58Once you get above 20 to 30 milligrams per day, you're more likely to see these.
- 39:03And if the person has not had a history of using it, we're more likely to see it.
- 39:07But a big issue is, even with legal marijuana, this is an important thing for you to know if you've got patients on that,
- 39:12if your patient was taking Xanax, you get pulled over, say "I have a prescription for Xanax" because you tested positive for the drug test, then for example, I write a letter
- 39:21and say this is a prescribed medication, they're taking it, no problem.
- 39:24That doesn't hold for THC.
- 39:26States do not give you the same latitude.
- 39:29And the same thing with drug tests and employers.
- 39:31Employers do not have to maintain or offer
- 39:35if you are using marijuana, even medically.
- 39:39Something very important for your patients to know.
- 39:42Some things about CBD.
- 39:44Typically at most doses, it does not impair driving.
- 39:47Higher doses in some people, you might get some mild sedation, but typically it's pretty good.
- 39:52We have seen, if people are on citalopram
- 39:55or escitalopram, there have been some reports of increased plasma concentrations.
- 40:00So you want to be careful about that.
- 40:01To give you an example, I'm using Alabama because I've just done something for the past three years for them.
- 40:06To prescribe marijuana, the prescriber has to pass an exam specifically on medical marijuana.
- 40:11They have to verify the patient has a qualifying condition, which the state outlines, and conventional therapy or medical treatment has failed.
- 40:18The patient has to show proof of state residency.
- 40:22They have to buy a medical card, marijuana card for 65 bucks.
- 40:25They have to be entered into a registry.
- 40:27A lot of states are doing this.
- 40:28Minors under 19 years old go through the same process, but they have to have a designated caregiver and both the caregiver and the patient have to be registered with the Cannabis
- 40:38Commission and be state residents.
- 40:42They clearly state that
- 40:42marijuana is not legalized for everyone.
- 40:43It's very specific.
- 40:44They recognize that recreational marijuana is still a threat.
- 40:47And if you are possessing, distributing or manufacturing, using marijuana without a license, you're looking at a class B felony.
- 40:55If you're greater than 70 daily doses, then you go to jail.
- 40:59They can prescribe it up to 12 months.
- 41:01The daily dosage can't exceed 50 milligrams, but can go to 75; but you've got to justify that it's medically appropriate or the patient is terminally ill.
- 41:11If they get 75 or greater than 75, their license is suspended.
- 41:14There are specific acceptable forms.
- 41:16One of the things that's been a concern, gummies and that's the non-sugar coated gelatinous cube.
- 41:21And there is going to be a state-determined flavor for the gummies in Alabama.
- 41:26And I think they're leaning towards peach.
- 41:29Medical marijuana cannot be smoked or vaped.
- 41:31Employers do not have to allow or accommodate it.
- 41:33And you can't sue the employer.
- 41:35If you're fired, you can be considered having to discharge from job because of misconduct; creates a real issue with certain states.
- 41:43So in the state that you're in, if you're involved with that, your patients need to be aware of that.
- 41:47The interesting thing is there's no registry that's been created.
- 41:50Dispensaries haven't been established, and so literally it's legalized, but really no way to do that.
- 41:56CBD basically can show up so products can have THC.
- 42:01It can show a positive drug test, as I've said before.
- 42:04One other thing I wanna mention: Cannabinoids have medical value, they do.
- 42:08Are they superior to existing medications?
- 42:10Not always.
- 42:11And since they are natural substances, a lot of people say they have no side effects, that is not correct.
- 42:17Every drug has side effects.
- 42:19Not all cannabinoids have the same effects.
- 42:21It depends on what is in each preparation.
- 42:24Just because it comes from state-approved sources doesn't necessarily mean it's consistent amounts of cannabinoids.
- 42:29We've seen that in Colorado.
- 42:30If you have a marijuana card, you're not protected in the workplace.
- 42:33The clinician can write me a prescription for cannabis?
- 42:36That depends on the particular state and what you're looking at.
- 42:39One of the big things that comes into play is CBD.
- 42:42We are finding a lot of Delta 8 and Delta-10.
- 42:45As a result of the farm law passed in 2018, I think it was, basically hemp products were made legal, which generated a lot of CBD,
- 42:55which can be converted to Delta 8.
- 42:57And what we're seeing is on the gummies, we're seeing large quantities of Delta 8 and even Delta 10 being added to the gummies by these manufacturers, which is creating a major
- 43:09issue.
- 43:10And many states are arguing with regard to that situation.
- 43:14Individuals who have TBI, could benefits ever outweigh the risk if impairment is there?
- 43:18That question really comes down to benefit/risk on that particular patient, what other options we have, and how impaired that patient may be.
- 43:28It also may come into play with how it may affect their overall lifestyle.
- 43:33It will be difficult, I would say, to do that.
- 43:35There are some cardiac effects that are coming out; we're still getting early reports of that.
- 43:39Is the psychosis attributed to the individuals using the wrong strain?
- 43:43Not always.
- 43:44And actually, my students, I usually give them recipes because they show up on the internet just to tell them what they're having there.
- 43:50I really appreciate your attention.
- 43:52And hope you have a wonderful day.
- 43:54Thank you, Dr.
- 43:54Tuckett.
- 43:55Good night, everyone.